Metadate CD Uses
Metadate CD uses primarily involve the treatment of attention deficit hyperactivity disorder (ADHD). It is approved for use in children ages six and older, but is not approved for use in adults. Despite this restriction, healthcare providers may occasionally recommend the drug for off-label reasons. These Metadate CD uses include weight loss, the treatment of adult ADHD, and narcolepsy treatment.
Metadate CD® (methylphenidate extended-release) is a prescription medicine that has been licensed to treat attention deficit hyperactivity disorder (ADHD).
ADHD is a condition involving difficulty paying attention, sitting still, and controlling behavior. In ADHD, these problems are worse than expected for a typical child of the same age. Usually, these symptoms must be present before the age of seven to qualify as ADHD. The symptoms must also affect school, work, or social life in a negative way (see ADHD and School and Relationships and ADHD for more information).
Although ADHD is generally thought of as a problem in children, teenagers and adults can also have it. The process used to diagnose ADHD in adults is different from that used to diagnose it in children.
In clinical trials, Metadate CD has been shown to help children and teenagers with ADHD. The medication can help them sit still and pay attention in the classroom and can help to improve behavior. However, the drug is not approved for use in adult ADHD (see Metadate and Adults).
Any behavioral change involves a well-balanced ADHD treatment plan, including social, educational, and mental therapy (see Behavior Therapy for ADHD). If lifestyle changes alone are not effective in changing behavior, ADHD medications (such as Metadate CD) may be necessary.